Press Releases
Search
-
25 Feb 2016
BioFire Receives FDA Clearance for FilmArray® Torch with FilmArray® Respiratory Panel and Submits Special 510(k) Applications for Use with additional FilmArray® Panels
FilmArray® Torch delivers high throughput, radically smaller footprint...
-
26 Jan 2016
BioFire’s FilmArray® Meningitis/Encephalitis Panel gets CE marked
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform...
-
20 Jan 2016
bioMérieux – Fourth-Quarter 2015 Business Review
Robust sales dynamic, driving 7.1% organic growth for the year: €1,965 million in sales Up 15.7% as reported Higher sales in every region, with an especially brisk 16% gain in the Americas. Strengthen...
-
12 Jan 2016
BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray® Torch, the New High Throughput FilmArray® System with FilmArray® Respiratory Panel
FilmArray® Torch delivers high throughput, radically smaller footprint...
-
05 Jan 2016
bioMérieux acquires Applied Maths and enhances its bioinformatics capabilities with cutting-edge expertise and solutions for the smart use of complex biological data
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the acquisition of Applied Maths, a company that develops state-of-the-art software solutions for the biosciences, in p...
-
14 Dec 2015
bioMérieux et Illumina annoncent le lancement de bioMérieux EpiSeq™, un service d’avant-garde en Séquençage Nouvelle Génération pour le suivi épidémiologique des infections bactériennes
bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeq™, an innovative next-generation seque...
-
04 Nov 2015
bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire
New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology...
-
22 Oct 2015
Information financière du 3e trimestre 2015
Robust growth in nine-month sales: Sales reached €1,412 million Up 18.3% as reported Up 8.3% at constant exchange rates and scope of consolidation Solid momentum in the Americas and EMEA1 regions in t...
-
09 Oct 2015
BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform...
-
24 Sep 2015
BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization
Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and Listing...
-
31 Aug 2015
bioMérieux – First-Half 2015 Results
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Sharp 34% improvement in contributive operating income before non-recurring items lifted by strong business m...
-
27 Jul 2015
bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®
Marcy l'Etoile, France, July 27, 2015 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This inst...
-
17 Jul 2015
First-Half 2015 Business Review
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up...
-
22 Jun 2015
Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux
For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat.
-
11 May 2015
2014 Financial Results
Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation Contributive operating income before non-recurring items...